Commentary to : Candidate for new heart failure and reduced ejection fraction therapy - angiotensin receptor-neprilysin inhibitor (ARNI) : clinician's guide
2353-7752
2353-7760
https://journals.viamedica.pl/folia_cardiologica/article/view/54518/41596
2019-07-19